Schedule 13D ownership disclosure

KalVista Pharmaceuticals Inc

Common Stock, $0.001 par value per share · CUSIP: 483497103

Event date: 2025-08-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.Reported CIK 0001863769

    Shares: 2,400,276.00 · Class: 4.8%

  • FHMLSP, L.P.Reported CIK 0001879466

    Shares: 2,400,276.00 · Class: 4.8%

  • FHMLSP, L.L.C.Reported CIK 0001879465

    Shares: 2,400,276.00 · Class: 4.8%

  • Frazier Life Sciences Public Overage Fund, L.P.Reported CIK 0001913804

    Shares: 946,074.00 · Class: 1.9%

  • FHMLSP Overage, L.P.Reported CIK 0001963247

    Shares: 946,074.00 · Class: 1.9%

  • FHMLSP Overage, L.L.C.Reported CIK 0001963248

    Shares: 946,074.00 · Class: 1.9%

  • Frazier Life Sciences X, L.P.Reported CIK 0001790879

    Shares: 1,156,869.00 · Class: 2.3%

  • FHMLS X, L.P.Reported CIK 0001790880

    Shares: 1,156,869.00 · Class: 2.3%

  • FHMLS X, L.L.C.Reported CIK 0001790811

    Shares: 1,156,869.00 · Class: 2.3%

  • Frazier Life Sciences XI, L.P.Reported CIK 0001911592

    Shares: 384,648.00 · Class: 0.8%

  • FHMLS XI, L.P.Reported CIK 0001911580

    Shares: 384,648.00 · Class: 0.8%

  • FHMLS XI, L.L.C.Reported CIK 0001911623

    Shares: 384,648.00 · Class: 0.8%

  • James N. TopperReported CIK 0001341382

    Shares: 1,156,869.00 · Class: 2.3%

  • Patrick J. HeronReported CIK 0001365617

    Shares: 1,156,869.00 · Class: 2.3%

  • Albert ChaReported CIK 0001397906

    Shares: 0.00 · Class: 0.0%

  • James BrushReported CIK 0001865123

    Shares: 0.00 · Class: 0.0%

  • Daniel EstesReported CIK 0001702527

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-022500
Form type
SCHEDULE 13D/A
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Aug 20, 2025
Reporting period
Aug 18, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub